This content is machine translated Interview: Prof. Dr. med. Dr. sc. nat. Heinz Läubli Promoting collaboration – at all levels Recently, Prof. Dr. Dr. Heinz Läubli, Head Physician for Oncology at the University Hospital Basel, received this year’s Annemarie Karrasch Research Award of the Basel Research Foundation propatient. Läubli’s research…
View Post 4 min This content is machine translated Psoriatic Arthritis Another JAK inhibitor has cleared the approval hurdle In patients with psoriatic arthritis who do not respond adequately to conventional DMARDs or a biologic, the EULAR recommendations advise the use of a JAK inhibitor. Recently, upadacitinib, another member…
View Post 10 min This content is machine translated Aesthetic dermatology Filler and thread lifting The natural aging process of the face leads to a loss of volume caused by the resorption of subcutaneous tissue. Over the years, not only the superficial and deep fat… CME-Test
View Post 11 min This content is machine translated Aggressive lymphomas Therapy in everyday clinical practice based on current developments Lymphoma accounts for 3.8% of all new cancer diagnoses. According to the current WHO classification, there are over 75 different lymphomentities, which are treated differently. In the treatment of diffuse… CME-Test
View Post 15 min This content is machine translated Self-management of teens with allergies or asthma Somehow it doesn’t work: adherence and compliance in adolescents Adolescents are difficult, don’t want to go to therapy, are unmotivated, are non-compliant: this is our common image of chronically ill adolescents. Is that really so? Or maybe it’s the… CME-Test
View Post 5 min This content is machine translated "Mild Cognitive Impairment" (MCI). How can progression be delayed? Patients with “Mild Cognitive Impairment” (MCI) have an increased risk of developing manifest dementia. The evidence on drug treatments that slow the progression of neurocognitive impairment is mixed. In terms of…
View Post 5 min This content is machine translated News from the lung cancer pipeline First targeted substance in KRAS mutation and bispecific immunotherapy While targeted therapies in non-small cell lung cancer (NSCLC) have been on the rise for years, such an option for KRAS-mutatedtumors has been lacking. The small molecule inhibitor Sotorasib, which…
View Post 3 min This content is machine translated Allergic rhinitis: sublingual specific immunotherapy Allergen extracts melt under the tongue Allergen-specific immunotherapy is currently the only causal therapy for the treatment of immediate-type allergies such as allergic rhinitis. In contrast to symptomatic therapies, the goal is to achieve sustained immunological…
View Post 2 min This content is machine translated Atherosclerosis Revolutionary therapeutic approach for cholesterol reduction in the starting blocks A new drug could revolutionize the management of cholesterol lowering. In Vienna, a new agent was used for the first time in the clinic, which is expected to reduce LDL…
View Post 1 min This content is machine translated PAVK Low-dose paclitaxel coating also effective in balloons Recent two-year results from the COMPARE trial – the world’s first prospective, randomized, controlled head-to-head study of two drug-coated balloons – showed that the one coated with a lower dose…
View Post 3 min This content is machine translated Blood pressure and lipid management Effects of effective therapy on cardiovascular health. A major factor in the development of atherosclerotic-related cardiovascular disease is the retention and accumulation of cholesterol-rich lipoproteins in the vessels. Therefore, in addition to adequate blood pressure control, the…
